

소개
Lung cancer remains a leading cause of cancer-related mortality worldwide, yet recent advances are reshaping its surgical and multidisciplinary management. Progress in minimally invasive and robotic surgical techniques, improved perioperative strategies, molecularly targeted therapies, and immunotherapy has fundamentally altered treatment paradigms and patient outcomes.



